The DEA is Rewriting Obama’s Federal Cannabis Regulations

This week, the federal government announced it would begin processing dozens of pending applications for the “steps necessary to improve access to marijuana research.” Additionally, companies hoping to obtain U.S. Drug Enforcement Agency Registration for a federal bulk manufacturer licenses to cultivate cannabis for scientific research as well as for manufacturing FDA- approved pharmaceuticals, are seemingly once step closer, with an arsenal of caveats. “I am pleased that DEA is moving forward with its review…


Go to Source

Powered by WPeMatico